Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (331-340 of 1,623) with videos related to

Pageof 163
Sort By:
Oncology|January 25, 2012
The promise and perils of measuring circulating tumor cellsMaurie Markman
Cancer Management and Research|July 28, 2011
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancerMaurie Markman
Nature Reviews. Clinical Oncology|December 21, 2011
Ovarian cancer in 2011: Mutations and non-inferiority analyses show a way forwardMaurie Markman
Gynecologic Oncology|May 31, 2011
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: a phase II study of the Gynecologic Oncology GroupMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Phase 1 trials of intensive antineoplastic therapy: a need for a critical reassessment of who should be treatedM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Cost: the new factor clinical cancer investigators must learn to considerM Markman
Cleveland Clinic Journal of Medicine|October 31, 1998
Why should cancer patients participate in clinical trials?M Markman
The Psychoanalytic Quarterly|April 1, 1997
Play in the treatment of adolescentsH Markman
Oncology|December 19, 2007
Use of systemic antineoplastic drug therapy after regulatory agency approvalMaurie Markman
Cleveland Clinic Journal of Medicine|February 2, 1999
Diagnosis and management of superior vena cava syndromeM Markman
Pageof 163

Showing results (331-340 of 1,623) with videos related to

Sort By:
Pageof 163
Oncology|January 25, 2012
The promise and perils of measuring circulating tumor cellsMaurie Markman
Cancer Management and Research|July 28, 2011
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancerMaurie Markman
Nature Reviews. Clinical Oncology|December 21, 2011
Ovarian cancer in 2011: Mutations and non-inferiority analyses show a way forwardMaurie Markman
Gynecologic Oncology|May 31, 2011
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: a phase II study of the Gynecologic Oncology GroupMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Phase 1 trials of intensive antineoplastic therapy: a need for a critical reassessment of who should be treatedM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Cost: the new factor clinical cancer investigators must learn to considerM Markman
Cleveland Clinic Journal of Medicine|October 31, 1998
Why should cancer patients participate in clinical trials?M Markman
The Psychoanalytic Quarterly|April 1, 1997
Play in the treatment of adolescentsH Markman
Oncology|December 19, 2007
Use of systemic antineoplastic drug therapy after regulatory agency approvalMaurie Markman
Cleveland Clinic Journal of Medicine|February 2, 1999
Diagnosis and management of superior vena cava syndromeM Markman
Pageof 163